Expression of Epstein–Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine
- 1 February 1999
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 17 (7-8), 660-668
- https://doi.org/10.1016/s0264-410x(98)00248-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Epstein-Barr Virus gp350-Specific Antibody Titers And Antibody-Dependent Cellular Cytotoxic Effector Function In Different Groups Of Patients: A Study Using Cloned gp350-Expressing Transfected Human T Cell TargetsThe Journal of Infectious Diseases, 1994
- Replication-defective recombinant adenovirus expressing the Epstein--Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarinJournal of General Virology, 1993
- Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vectorJournal of General Virology, 1992
- Mapping of the epitopes of Epstein--Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinantsJournal of General Virology, 1991
- Validation of a first‐generation epstein‐barr virus vaccine preparation suitable for human useJournal of Medical Virology, 1989
- Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challengeJournal of Medical Virology, 1989
- Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosisCell, 1987
- Epitope Mapping of the Major Epstein-Barr Virus Outer Envelope Glycoprotein gp350/220Journal of General Virology, 1987
- Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNACell, 1986
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972